Effectiveness of V-Go(®) for Patients with Type 2 Diabetes in a Real-World Setting: A Prospective Observational Study

BACKGROUND: V-Go is a wearable, patch-like, 24-h insulin delivery device that delivers both a continuous preset basal rate and on-demand bolus dosing. The aim of this study was to observe glycemic control, insulin dosing, and hypoglycemia risk in patients switched to V-Go in a real-world setting. Th...

Descripción completa

Detalles Bibliográficos
Autores principales: Grunberger, George, Rosenfeld, Cheryl R., Bode, Bruce W., Abbott, Scott D., Nikkel, Carla, Shi, Leon, Strange, Poul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2019
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7060972/
https://www.ncbi.nlm.nih.gov/pubmed/31833010
http://dx.doi.org/10.1007/s40801-019-00173-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7060972/
https://www.ncbi.nlm.nih.gov/pubmed/31833010
http://dx.doi.org/10.1007/s40801-019-00173-8

Ejemplares similares